期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌新辅助化疗的最新研究进展 被引量：4

暂未订购
导出
摘要 乳腺癌是女性常见肿瘤之一，目前约占女性全身恶性肿瘤的7％-10％，且有年轻化趋势。临床上以根治性切除为主要治疗方法，术后常需辅助化疗。2007年NCCN指南提出对于Ⅱ、Ⅲ乳腺癌患者可给予新辅助化疗闭。本文就乳腺癌新辅助化疗的一些最新研究现状及展望做一综述。
作者 胡巍
机构地区 贵港市中西医结合骨科医院
出处 《中外医学研究》 2013年第7期152-153,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 乳腺癌 辅助化疗 研究进展
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Bleyer A.Young adult oncology: the patients and their survival challenges[J]. C A CancerJ Clin, 2007, 57(4): 242-255.
  • 2王晓稼.乳腺癌新辅助化疗的共识与争议[J].中国肿瘤,2007,16(10):788-792. 被引量：25
  • 3FisherB, GunduzN, Saffer E A.Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases[J]. CancerRes, 1983, 43(4): 1488-1492.
  • 4Gunduz N, Fisher B, Saffer E A.Effect of surgical removal on the growth andkineticsofresidualtumor[J].CancerRes, 1979, 39(10): 3861-3865.
  • 5Erol K, Baltali E, Altundag K, et al.Neoadjuvant chemotherapy with cyclophosphamide, mitoxantrone, and 5-fluorouracil in locally advanced breast cancer[J].Onkologie, 2005, 28(2): 81-85.
  • 6蔡海峰,赵刚,潘惠承.新辅助化疗在隐匿性乳腺癌中的应用[J].中国综合临床,2006,22(6):538-539. 被引量：4
  • 7Estevez L G, Senchez-Rovira P, Demine M, et al.Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage Ⅱ and Ⅲ breast cancer patients: results of a phase Ⅱ study[J].Clin Transl Oncol, 2007, 9(5): 317-322.
  • 8Mouret R M A, Abrial C J, Ferriere J P, et al.Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at centre Jean perrin[J].Clin Breast Cancer, 2004, 5(4): 303-307.
  • 9Andrade J M, Carrara H H, Pimentel F F, et al.Taxane-based chemotherapy enhances response to neoadjuvant treatment for stage Ⅱ and Ⅲ breast cancer[J].Med Oncol, 2010, 16(10): 1007.
  • 10Strayer M E, Adrichem J C, Rutgers E J, et al.Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy[J].Ned Tijdschr Geneeskd, 2008, 152(46): 2519-2525.

二级参考文献29

  • 1Fisher B,Mamounas EP.Preoperative chemotherapy:a model for studying the biology and therapy of primary breast cancer[J].J Clin Oncol,1995,13(3):537-540.
  • 2Swain SW,Sorace RA,Bagley CS,et al.Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer[J].Cancer Res,1987,47(12):3 889-3 894.
  • 3Buzdar AU,Singletary SE,Theriault RL,et al.Prospective evaluation of paclitaxe versus combination chemotherapy with fluorouracil,doxorubicin and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer[J].J Clin Oncol,1999,17(11):3 412-3 417.
  • 4Smith IC.Neoadjuvant chemotherapy in breast cancer:significantly enhanced with docetaxel[J].J Clin Oncol,2002,20(6):1 456.
  • 5Fisher B,Brown A,Mamounas E,et al.Effect of preoperative chemotherapy on local-regional diseases in women with operable breast cancer:finding from nation surgical adjuvant and bowel project B-18[J].J Clin Oncol,1997,15(7):2 483-2 493.
  • 6Wolmark N,Wang J,Manounas E,et al.Preoperative chemotherapy in patients with operable breast cancer:nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18[J].J Natl Cancer Inst Monogr,2001,(30):96-102.
  • 7Kaufmann M,Hortobagyi GN,Goldhirsch A,et al.Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer:an update[J].J Clin Oncol,2006,24(12):1940-1949.
  • 8Shimizu C,Ando M,Kouno T,et al.Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer[J].Jpn J Clin Oncol,2007,37(1):1-8.
  • 9Bear HD,Anderson S,Smith RE,et al.Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27[J].J Clin Oncol,2006,24(13):2019-2027.
  • 10Trudeau M,Sinclair SE,Clemons M,et al.Neoadjuvant taxanes in the treatment of non-metastatic breast cancer:a systematic review[J].Cancer Treat Rev,2005,31 (4):283-302.

共引文献27

同被引文献58

  • 1王少华,赵瑞峰.磁共振成像诊断乳腺癌的研究进展[J].现代医用影像学,2012,21(1):8-11. 被引量：4
  • 2罗智辉,孔令言.紫杉醇联合顺铂的新辅助化疗治疗乳腺癌的临床观察[J].热带医学杂志,2005,5(5):693-694. 被引量：2
  • 3Kejin Wu, Ziyi Weng, Qinghua Tao, et al. Stage-specific expression of breast cancer-specific gene ~/-synuclein[J]. Cancer Epidemiology Biomarkers Prevention, 2003,12 (9) :920.
  • 4Harry D. Bear, Stewart Anderson, Roy E. Smith, et al. Sequential preoperative or postoperative docetaxel added to preoperative Doxorubiein Plus Cyelophos phamide for Operable breast cancer: National surgical adjuvant breast and bowel project protocol B-27 [J]. American Society of Clinical Ontology, 2006,24 (13) : 2019-2027.
  • 5B Sirohi, M Arnedos,S Popat,et al. Platinum-based chemotherapy in triple-negative breast cancer[J]. AnnOneol, 2008,19 ( 11 ) : 1847-1852.
  • 6王殊,杨后圃,张嘉庆,等.三阴性乳腺癌的新辅助化疗疗效及预后分析[C].第五届中国肿瘤学术大会教育集.557-560.
  • 7Foulkes William D,Smith Ian E,Reis-Filho Jorge S.Triple-negative breast cancer. The New England Quarterly . 2010
  • 8Cornelia Liedtke,Chafika Mazouni,Kenneth R. Hess,Fabrice André,Attila Tordai,Jaime A. Mejia,W. Fraser Symmans,Ana M. Gonzalez-Angulo,Bryan Hennessy,Marjorie Green,Massimo Cristofanilli,Gabriel N. Hortobagyi,Lajos Puszt.Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer. Japanese Journal of Clinical Oncology . 2008
  • 9Gloria J.Morris,SashiNaidu,Allan K.Topham,FranGuiles,YihuanXu,PeterMcCue,Gordon F.Schwartz,Pauline K.Park,Anne L.Rosenberg,KristinBrill,Edith P.Mitchell.??Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients(J)Cancer . 2007 (4)
  • 10Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study(J)Breast Cancer Research and Treatment . 2010 (1)

引证文献4

二级引证文献18

中外医学研究
2013年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部